Login

Exclusive interview with Larry Ellison, CEO of Oracle Corp, discussing the future of technology and business strategies. 00:10:00

Share On Facebook Share On Twitter

Oracle Japan's CEO is Toshimitsu Misawa, 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Chip Kaye on the Importance of People in Investment Decisions and the Influence of Asia
00:10:00
Investment in digital bank Revolut, valued at $25.7 billion|Martin Mignot,investor,Index Ventures
00:10:00
The Owner’s Mentality: Insights from Greg Padilla, Portfolio Manager at Aristotle Capital
00:10:00
Mutual of Omaha Advisors: Redefining Careers with Professional Growth and Personal Balance
00:10:00
Evolution of Investment Excellence: A CEO's Vision for Wellington Management | Jean Hynes , CEO , Wellington Management.
00:10:00
From Oilfields to Global Finance: Khaldoon Al Mubarak’s Path to Leading Mubadala Investment Company | Khaldoon Al Mubarak - CEO, Mubadala Investment Company
00:10:00
Exploring Market Performance and Trends | Joanna Arnold, Chief Executive Officer, Access Intelligence PLCACC:LSE
00:10:00
Determining Your Mortgage Affordability: Key Considerations | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Discover develop and deliver innovative therapies for the treatment of advanced solid tumors and other major diseases|David J. Mazzo,President,Caladrius Biosciences Inc
00:10:00
Rumble Resources Expands High-Grade Gold Potential at Western Queen Project
00:10:00
Andrew Roberts on the Military Prowess of WWII Germany and Alternate Histories
00:10:00
Interview with Michael Danoff, Chief Investment Officer and President at SBP Investments

© 2017 - Neuhu+